This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Imagine youre trying to reach a specialist in a bustling hospitalyour message is a whisper in a sea of noise. How do you get through? In the complex world of healthcare, pharmaceutical marketing strategies must evolve to genuinely connect with healthcare professionals (HCPs). No longer effective are blanket tactics or generic messaging. Instead, today’s successful marketers are leveraging personalized, data-driven, and omnichannel approaches that meet HCPs where they are.
By Charles D. Snow Operation Stork Speed is a go! On March 18, 2025, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) launched a significant initiative called Operation Stork Speed to bolster the availability and safety of infant formula in the United States (see our previous blog post here ). The March announcement outlined six key actions underlying Operation Stork Speed, including the launch of the first comprehensive review of infant formula
Can a flashy website really move the needle for an oncology brand? Is social media too risky for pharma compliance? These questions reflect some of the biggest myths in digital marketing in pharma , an area that continues to evolve at warp speed yet remains tethered by legacy thinking. Many marketers in the pharmaceutical industry struggle to balance innovation with regulation, often falling into traps set by outdated beliefs.
Naxitamab-gqgk has been added as a Category 2A recommendation in the updated National Comprehensive Cancer Network (NCCN) guidelines for high-risk neuroblastoma, reflecting growing consensus on its role in treating relapsed or refractory disease.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Can a flashy website really move the needle for an oncology brand? Is social media too risky for pharma compliance? These questions reflect some of the biggest myths in digital marketing in pharma , an area that continues to evolve at warp speed yet remains tethered by legacy thinking. Many marketers in the pharmaceutical industry struggle to balance innovation with regulation, often falling into traps set by outdated beliefs.
In this episode, I’ll discuss probiotic-associated central venous catheter bloodstream infections in the ICU. Episode 1027: Probiotics in the ICU - How Bad Can It Get? Subscribe on iTunes , Android , or Stitcher While probiotics are typically seen as a harmless intervention that may have benefits related to antibiotic-associated diarrhea, bloodstream infections caused by organisms contained within probiotics have been reported in ICU patients.
WASHINGTON — Former President Joe Biden has been diagnosed with prostate cancer, his office said Sunday. Biden was seen last week by doctors after urinary symptoms and a prostate nodule was found. He was diagnosed with prostate cancer on Friday, with the cancer cells having spread to the bone.
148
148
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
WASHINGTON — Former President Joe Biden has been diagnosed with prostate cancer, his office said Sunday. Biden was seen last week by doctors after urinary symptoms and a prostate nodule was found. He was diagnosed with prostate cancer on Friday, with the cancer cells having spread to the bone.
GSKs Nucala (mepolizumab) demonstrated a consistent reduction in exacerbation rates among patients with eosinophilic chronic obstructive pulmonary disease (COPD), irrespective of prior severe event history, according to findings presented at the 2025 American Thoracic Society (ATS) International Conference. These results further solidify the role of IL-5 inhibition in biomarker-driven COPD management, says GlobalData, a leading data and analytics company.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
JK is a 77-year-old male who reports a 1-week history of intermittent dizziness and episodes of loss of balance, particularly when walking around. He denies any recent falls, headaches, visual changes, or chest pain. He describes the sensation as “lightheaded” and like the room spins a little. Past Medical History: Current Medications: What should be […] The post Loss of Balance Case Study appeared first on Med Ed 101.
The recent US executive order on prescription drug pricing, signed by President Trump on May 12, 2025, aims to align American drug prices with those in other developed nations through a most-favored-nation (MFN) framework. While the policy is designed to cut costs for US patients, its effects are likely to have far reaching impact globally, presenting both challenges and opportunities for Indias pharmaceutical sector.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
52 
Let's personalize your content